AbVision

Business Services · Nevada, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1575 Delucchi Ln, Reno, Nevada, 89502, U...

Phone Number

(408) 493-1822

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About AbVision

AbVision, Inc. is a biopharmaceutical company based in the San Francisco Bay Area, specializing in the discovery and development of therapeutic antibodies, vaccines, and cell therapies. The company utilizes innovative technology platforms, such as SpeedyAb and ImmunoBuster, to create next-generation bio-therapeutics aimed at treating cancer and infectious diseases. AbVision's product pipeline includes advanced candidates like the anti-CD47 therapeutic antibody AVI-105 and a novel COVID-19 vaccine candidate, AVI-205, both available for out-licensing and collaborations. Their target clients include pharmaceutical companies and research institutions seeking to develop and commercialize cutting-edge therapies.Explore more
AbVision's Social MediaPopular SearchesAbvision IncAbVisionSIC Code 87,873NAICS Code 54,541Show more

AbVision Org Chart

PhoneEmail
MC
United States flag for contact location.

Founder & Chief Operating Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
EC
United States flag for contact location.

Manager, Laboratory Operations & Research Ass...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is AbVision your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to AbVision

Compare insights from companies similar to AbVision, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

AbVision

<$5M
11-50
Private
-
2018
MC
Mark ChenFounder & Chief Operating Officer
$5.4M
11-50
Private
-
2013
GC
Guoqing ChenPresident & CEO
$5.3M
11-50
Private
$83.5M
2005
<$5M
11-50
Private
-
1998
PL
Phillip LiuSenior Director
<$5M
11-50
Private
$39M
2016
Michael Fehlings, Chief Executive Officer & Chief Technology Officer at ImmunoScape
Michael FehlingsCEO & Chief Technology Officer
<$5M
11-50
Private
-
2012
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

AbVision is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

AbVision is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AbVision.

AbVision Tech Stack

A closer look at the technologies used by AbVision

AbVision News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding AbVision

What is AbVision's official website?
AbVision's official website is www.abvisioninc.com
What is AbVision's Revenue?
AbVision's revenue is <$5 Million
What is AbVision's SIC code?
AbVision's SIC: 87,873
What is AbVision's NAICS code?
AbVision's NAICS: 54,541
How many employees does AbVision have?
AbVision has 11-50 employees
What industry does AbVision belong to?
AbVision is in the industry of: Business Services, Research & Development
What is AbVision competition?
AbVision top competitors include: Immunomic Therapeutics, Sound Biologics, ImmunoScape, Nanobiotec
What technology does AbVision use?
Some of the popular technologies that AbVision uses are: Hostgator, Hostgator Email
How do I contact AbVision?
AbVision contact info: Phone number: (408) 493-1822 Website: www.abvisioninc.com
What does AbVision do?

AbVision, Inc. is a biopharmaceutical company based in the San Francisco Bay Area, specializing in the discovery and development of therapeutic antibodies, vaccines, and cell therapies. The company utilizes innovative technology platforms, such as SpeedyAb and ImmunoBuster, to create next-generation bio-therapeutics aimed at treating cancer and inf... ectious diseases. AbVision's product pipeline includes advanced candidates like the anti-CD47 therapeutic antibody AVI-105 and a novel COVID-19 vaccine candidate, AVI-205, both available for out-licensing and collaborations. Their target clients include pharmaceutical companies and research institutions seeking to develop and commercialize cutting-edge therapies.Read More

What are AbVision social media links?
AbVision Linkedin page AbVision Facebook page
Is AbVision a public company?
AbVision is private company therefore does not currently have an official ticker symbol
See more information about AbVision

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.